Who Paid My Doc
NCT06423430--Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Research payments
$1,022,404
Through program year 2025, $1,022,404 in research payments was reported against NCT06423430--Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND), across 308 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,022,404 | 308 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Charles Conway Saint Louis, MO Named on 24 payments
- Martijn Figee New York, NY Named on 22 payments
- Patricio Riva Posse Atlanta, GA Named on 22 payments
- Alik Widge Minneapolis, MN Named on 18 payments
- Kala Bailey Dallas, TX Named on 18 payments
- Andrew Leuchter Los Angeles, CA Named on 17 payments
- Mark George Charleston, SC Named on 17 payments
- Katherine Scangos Sacramento, CA Named on 17 payments
- Robert Gross Atlanta, GA Named on 16 payments
- Kendall Lee Rochester, MN Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.